LBO — UH GENEVA MEDICAL CENTER
IRR: 16.9% | MOIC: 2.18x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
16.9%
IRR
2.18x
MOIC
$69.9M
Entry EV
$106.3M
Exit EV
$36.0M
Equity Invested
Sources & Uses
S&UTotal · $69.9M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $27.1M | 38.8% | |
| Sub Debt | $6.8M | 9.7% | |
| Equity | $36.0M | 51.5% | |
| Enterprise Value | $67.8M | 97.1% | |
| Transaction Fees | $2.0M | 2.9% | |
| Total Uses | $69.9M | 100.0% |
Interpretation
INTAt 2.18x MOIC and 16.9% IRR over 5 years, this deal meets the 15-20% range — acceptable with operational upside.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $10.1M |
| Exit Ev | $106.3M |
| Net Debt At Exit | $28.0M |
| Equity At Exit | $78.4M |
| Equity Invested | $36.0M |
| Total Value Created | $42.4M |
| Value From Growth | $35.1M |
| Value From Multiple | $3.4M |
| Value From Deleveraging | $6.0M |